2010
DOI: 10.1111/j.1468-3083.2009.03441.x
|View full text |Cite
|
Sign up to set email alerts
|

PTH‐independent hypercalcaemia and non‐melanoma skin cancer

Abstract: PTH-independent hypercalcaemia has a low prevalence in SCC patients. Hypercalcaemia is correlated with susceptibility to develop metastases in SCC. A possible mechanism is PTHrp hypersecretion by malignant keratinocytes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
9
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 12 publications
(22 reference statements)
1
9
0
Order By: Relevance
“…PTHrP levels are hypothesized to reflect tumor burden and may be useful in monitoring response to treatment or tumor progression in select patients with HHM (2). The prevalence of PTH-independent hypercalcemia was noted to be 1.2% in patients with SCC, thus emphasizing the rare occurrence of this association between cutaneous SCC and hypercalcemia (18). Despite molecular similarity and data indicating that PTHrP analogues can mirror the effect of PTH in vitro, HHM differs significantly from primary hyperparathyroidism, as patients with HHM are less likely to manifest hypertension, renal calculi, band keratopathy, or osteopenia (19).…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation
“…PTHrP levels are hypothesized to reflect tumor burden and may be useful in monitoring response to treatment or tumor progression in select patients with HHM (2). The prevalence of PTH-independent hypercalcemia was noted to be 1.2% in patients with SCC, thus emphasizing the rare occurrence of this association between cutaneous SCC and hypercalcemia (18). Despite molecular similarity and data indicating that PTHrP analogues can mirror the effect of PTH in vitro, HHM differs significantly from primary hyperparathyroidism, as patients with HHM are less likely to manifest hypertension, renal calculi, band keratopathy, or osteopenia (19).…”
Section: Discussionmentioning
confidence: 96%
“…PTHrP has high affinity for the PTH/PTHrP receptor, through which it exerts its effects (9). PTHrP induces bone resorption and decreases bone formation, thereby affecting whole-body calcium distribution, resulting in hypercalcemia, while at the renal level, it stimulates phosphaturia and inhibits urinary calcium absorption (18). PTHrP levels are hypothesized to reflect tumor burden and may be useful in monitoring response to treatment or tumor progression in select patients with HHM (2).…”
Section: Discussionmentioning
confidence: 99%
“…In a single center study with 412 patients with cutaneous squamous cell carcinoma (SCC), Nicolae et al . reported a low PTH-independent hypercalcemia prevalence of 1.21% [7]. Furthermore, two cases with hypercalcemia-hyperleukocytosis paraneoplastic syndrome in cutaneous squamous cell carcinoma were described [8].…”
Section: Discussionmentioning
confidence: 99%
“…The patient's tumour was deemed inoperable, and not amenable to systemic chemotherapy due to poor performance status; therefore, palliative radiotherapy was initiated.
Learning points Distant osseous metastases from cutaneous squamous cell carcinoma are rare and the underlying humoral mechanism involves parathyroid hormone-related peptide overproduction by the tumour 1. Intriguingly, low but detectable serum intact parathyroid hormone levels are also involved in the development of humoral hypercalcaemia of malignancy 2
…”
Section: Descriptionmentioning
confidence: 99%
“…Distant osseous metastases from cutaneous squamous cell carcinoma are rare and the underlying humoral mechanism involves parathyroid hormone-related peptide overproduction by the tumour 1. Intriguingly, low but detectable serum intact parathyroid hormone levels are also involved in the development of humoral hypercalcaemia of malignancy 2…”
Section: Descriptionmentioning
confidence: 99%